Stay updated on UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial
Sign up to get notified when there's something new on the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page.

Latest updates to the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page
- Check2 days agoChange DetectedRecruitment has ceased for this study, and new guidance sections have been added to help users read the study record and join the study. A formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' and the page revision update to v3.6.0 are also included.SummaryDifference0.5%

- Check9 days agoChange DetectedThe page now displays a revision tag updating from v3.5.4 to v3.5.5, indicating a maintenance or backend update. This change does not modify the trial content or critical functionality for users.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA metadata revision was issued, updating the page from Revision v3.5.3 to Revision v3.5.4. This reflects a minor update to the documentation/versioning of the page and does not modify the study content or presented data.SummaryDifference0.0%

- Check45 days agoChange DetectedA new revision tag (v3.5.3) has been added, replacing the previous v3.5.2. This indicates a minor update to the site’s revision history rather than a substantive change to the study details.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2. This change does not affect the study details or visible content.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible changes to the study details content or layout were observed.SummaryDifference0.0%

Stay in the know with updates to UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCB0942 in Highly Drug-resistant Focal Epilepsy Clinical Trial page.